65 related articles for article (PubMed ID: 38614981)
1. A novel risk signature based on liquid-liquid phase separation-related genes reveals prognostic and tumour microenvironmental features in clear cell renal cell carcinoma.
Lu Q; Xi P; Xu S; Zhang Z; Gong B; Liu J; Zhu Q; Sun T; Zhu S; Chen R
Aging (Albany NY); 2024 Mar; 16(7):6118-6134. PubMed ID: 38546385
[TBL] [Abstract][Full Text] [Related]
2. Deciphering anoikis resistance and identifying prognostic biomarkers in clear cell renal cell carcinoma epithelial cells.
Li J; Cao Q; Tong M
Sci Rep; 2024 May; 14(1):12044. PubMed ID: 38802480
[TBL] [Abstract][Full Text] [Related]
3. Radiomics Model for Predicting FOXP3 Expression Level and Survival in Clear Cell Renal Carcinoma.
Wang J; Huang Z; Zhou J
Acad Radiol; 2024 Apr; 31(4):1447-1459. PubMed ID: 37940428
[TBL] [Abstract][Full Text] [Related]
4. CT-Based Radiogenomics of P4HA3 Expression in Clear Cell Renal Cell Carcinoma.
Greco F; Panunzio A; Tafuri A; Bernetti C; Pagliarulo V; Zobel BB; Scardapane A; Mallio CA
Acad Radiol; 2024 Mar; 31(3):902-908. PubMed ID: 37537130
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of ST6GalNAc-1 expression in patients with non-metastatic clear cell renal cell carcinoma.
Bai Q; Liu L; Xi W; Wang J; Xia Y; Qu Y; Xiong Y; Long Q; Xu J; Guo J
Oncotarget; 2018 Jan; 9(3):3112-3120. PubMed ID: 29423033
[TBL] [Abstract][Full Text] [Related]
6. Network analysis of histopathological image features and genomics data improving prognosis performance in clear cell renal cell carcinoma.
Ji J; Liu Y; Bao Y; Men Y; Hui Z
Urol Oncol; 2024 Aug; 42(8):249.e1-249.e11. PubMed ID: 38653593
[TBL] [Abstract][Full Text] [Related]
7. Construction and Validation of a Mutation-Related Model in Papillary Renal Cell Carcinoma and Associated Immune Infiltration.
Li X; Liu Y; Zhou L; Wang J; Yang X
Kidney Blood Press Res; 2024; 49(1):355-367. PubMed ID: 38714185
[TBL] [Abstract][Full Text] [Related]
8. Multi-cohort validation: A comprehensive exploration of prognostic marker in clear cell renal cell carcinoma.
Li Y; Fan C; Hu Y; Zhang W; Li H; Wang Y; Xu Z
Int Immunopharmacol; 2024 Jun; 135():112300. PubMed ID: 38781609
[TBL] [Abstract][Full Text] [Related]
9. The Expression Patterns of FAM83H and PANX2 Are Associated With Shorter Survival of Clear Cell Renal Cell Carcinoma Patients.
Kim KM; Hussein UK; Bae JS; Park SH; Kwon KS; Ha SH; Park HS; Lee H; Chung MJ; Moon WS; Kang MJ; Jang KY
Front Oncol; 2019; 9():14. PubMed ID: 30723706
[TBL] [Abstract][Full Text] [Related]
10. Identification of metabolism-associated genes and pathways involved in different stages of clear cell renal cell carcinoma.
Li HJ; Li WX; Dai SX; Guo YC; Zheng JJ; Liu JQ; Wang Q; Chen BW; Li GH; Huang JF
Oncol Lett; 2018 Feb; 15(2):2316-2322. PubMed ID: 29434939
[TBL] [Abstract][Full Text] [Related]
11. Dynamic changes of SCGN expression imply different phases of clear cell renal cell carcinoma progression.
Guo T; Wang X; Wang T; Zhang J; Liu Y; Chen S; Wang X; Yang X; Wang C; Wang X
Discov Oncol; 2024 Jun; 15(1):205. PubMed ID: 38831128
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of nuclear expression of PHF2 and C/EBPα in clear cell renal cell carcinoma with consideration of adipogenic metabolic evolution.
Park JH; Jung M; Moon KC
Oncotarget; 2018 Jan; 9(1):142-151. PubMed ID: 29416602
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of myoferlin expression in patients with clear cell renal cell carcinoma.
Song DH; Ko GH; Lee JH; Lee JS; Yang JW; Kim MH; An HJ; Kang MH; Jeon KN; Kim DC
Oncotarget; 2017 Oct; 8(51):89033-89039. PubMed ID: 29179496
[TBL] [Abstract][Full Text] [Related]
14. PSAT1 enhances the efficacy of the prognosis estimation nomogram model in stage-based clear cell renal cell carcinoma.
Wang J; He X; Mi Y; Chen YQ; Li J; Wang R
BMC Cancer; 2024 Apr; 24(1):463. PubMed ID: 38614981
[TBL] [Abstract][Full Text] [Related]
15. Construction of the metabolic reprogramming-associated gene signature for clear cell renal cell carcinoma prognosis prediction.
Tai R; Leng J; Li W; Wu Y; Yang J
BMC Urol; 2023 Sep; 23(1):147. PubMed ID: 37715154
[TBL] [Abstract][Full Text] [Related]
16. Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma.
He Z; Deng T; Duan X; Zeng G
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32789468
[TBL] [Abstract][Full Text] [Related]
17. An immune scores-based nomogram for predicting overall survival in patients with clear cell renal cell carcinoma.
Wu Z; Ouyang C; Peng L
Medicine (Baltimore); 2020 Aug; 99(34):e21693. PubMed ID: 32846785
[TBL] [Abstract][Full Text] [Related]
18. Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma.
Zhang Z; Lin E; Zhuang H; Xie L; Feng X; Liu J; Yu Y
Cancer Cell Int; 2020; 20():27. PubMed ID: 32002016
[TBL] [Abstract][Full Text] [Related]
19. Nomogram Based on microRNA Signature Contributes to Improve Survival Prediction of Clear Cell Renal Cell Carcinoma.
Zhao E; Bai X
Biomed Res Int; 2020; 2020():7434737. PubMed ID: 32280701
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
